The AHDB Team is delighted to announce the partnership with #METASTRA: Transforming Fracture Risk Assessment for Cancer Patients with Vertebral Metastases
The project, funded by EU’s Horizon Europe “Tools and technologies for a healthy society”, aims at leading a transformative approach to revolutionize fracture risk assessment and personalized treatment for cancer patients with vertebral metastases.
We will support healthcare professionals in the execution of clinical research, the management of heterogeneous #clinicaldata within the #AHDB platform, and the formulation of methodologies for achieving the desired outcomes.
To know more about Metastra: Metastra Linkedin page
Follow our Linkedin page for more updates about our collaborations and initiatives
The new infrastracture for clinical research studies